miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
![Thumbnail](/themes/Mirage2/images/white_rectangle.jpeg)
File Type:
PDFItem Type:
Published AbstractDate:
2014Author:
Access:
openAccessCitation:
Corcoran C, Rani S, Prencipe M, O'Neill A, Watson W, O'Driscoll L., miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression., J. Extracellular Vesicles., 3, 24214, 2014, 360 - 360Download Item:
Author's Homepage:
http://people.tcd.ie/lodriscDescription:
PUBLISHED
Author: O'Driscoll, Lorraine
Other Titles:
J. Extracellular Vesicles.Type of material:
Published AbstractSeries/Report no:
324214
Availability:
Full text availableSubject (TCD):
CancerDOI:
http://dx.doi.org/10.3402/jev.v3.24214Metadata
Show full item recordLicences: